Type: Press Release
… (NASDAQABMD) announced that on Thursday October 26 2017 the Company will release financial results for the second quarter of fiscal 2018 The Company will host a conference call to … 26 2017 through 1100 am EDT on October 29 2017 The replay phone number is (855) 859-2056 the international number is …
Type: Press Release
… (NASDAQABMD) announced that on Thursday January 26 2017 the Company will release financial results for the third quarter of fiscal 2017 The Company will host a conference call to … 26 2017 through 11 am EST on January 29 2017 The replay phone number is (855) 859-2056 the international number is …
Type: Press Release
… (BTR) as part of the heart pump’s US Food and Drug Administration (FDA) Early Feasibility Study (EFS) The first implant was done by Duc Thinh Pham MD and Jane Wilcox MD at Northwestern … failure For additional information please visit wwwabiomedcom ABOUT IMPELLA HEART PUMPS The Impella 25® and Impella …
Type: Press Release
… multimedia View the full release here https//wwwbusinesswirecom/news/home/20190502005270/en/ The STEMI DTU safety and … mortality or hospitalization for heart failure within one year after a primary PCI1 Coronary artery disease is the … based on primary endpoint and safety data analysis Endpoints Primary Endpoint - Infarct size as a percent of left …
Type: Press Release
… the world’s largest most diversified healthcare products company today announced it has completed its acquisition of Abiomed Inc Abiomed is now part of Johnson & Johnson and will operate as a standalone business within Johnson & Johnson’s MedTech segment “We …
Type: Press Release
… use of Abiomeds (NASDAQABMD) Impella heart pumps in high-risk PCI cardiogenic shock and right heart failure patients … Impella SmartAssist technology enables improved patient outcomes via real-time intelligence Abiomed augments limited … Presenters PROTECT Series Leading to PROTECT IV Gregg Stone MD Mount Sinai Health System New York City Real World …
Type: Press Release
… and medical device trade association AdvaMed will also welcome a new partner BioCollaborative to assist in reaching … professionals and veterans that have already transitioned into successful civilian roles at medtech or biotech … and customized training will enable more touch points and hands-on training for MVP veterans to learn …
Type: Press Release
… Organization (CDSCO) approval in India for use during high-risk percutaneous coronary intervention (PCI) cardiogenic … and presented with severe recurrent chest pain and multiple comorbidities A diagnostic catheterization demonstrated … recovery of the native heart Heart disease is the number one cause of death in India1 and of those diagnosed with …
Type: Press Release
… DANVERS Mass and SAN FRANCISCO Jan 09 2017 (GLOBE NEWSWIRE) -- Abiomed Inc … revenue of approximately $1147 million an increase of 34% compared to revenue of $858 million for the same period of … 26 2017 through 11 am EST on January 29 2017 The replay phone number is (855) 859-2056 the international number is …
Type: Press Release
… data from seven research studies focused on optimizing outcomes for patients receiving Impella-supported high-risk percutaneous coronary intervention (HRPCI) will be … Clinical Science & Research Hall C Exhibition Level Moscone South Additional Impella HRPCI abstracts being …